Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
FLAC was delisted on the 22nd of November, 2022.
35 hedge funds and large institutions have $50M invested in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$7.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$5.61M |
| 3 |
DCM
DG Capital Management
New York
|
+$4.49M |
| 4 |
GL
Governors Lane
New York
|
+$3.57M |
| 5 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$2.55M |
Top Sellers
FLAC Hedge Fund Activity: Q1 2021 in Review
35 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) for Q1 2021, worth a combined $50M.
Buyers outnumbered sellers: 35 funds opened new FLAC positions and 0 closed out — a net gain of 35 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $7.3M.
- 35 institutional investors held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) as of Q1 2021, up from 0 in Q4 2020.
- Funds reported $50M of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares stock for Q1 2021.
- 35 funds opened new Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares positions in Q1 2021 and 0 closed out, a net change of +35 holders.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares buyer in Q1 2021 was Alyeska Investment Group, an estimated $7.3M added.
Based on aggregated 13F filings for Q1 2021.